Cognitum's Iosif M. Gershteyn discusses partial epigenetic reprogramming, Yamanaka factors, and theoretical underpinnings of aging and its reversal with Yuri Deigin, founder of YouthBio Therapeutics and a longtime activist in the longevity field. Yuri comes from a background of pharmaceutical drug development where he had started and led a number of biotech companies. He was one of the earliest believers in the potential of partial reprogramming as an approach to slowing down or even reversing aging, with his first foray into the translation of this approach in 2017, and continuing with it to this day.
Twitter: @ydeigin
Supported by the Ajax Biomedical Foundation
Directed by John Fremer
Produced by mashaStudio (c) 2022
![](https://s2.save4k.ru/pic/8hZND8HWtwU/mqdefault.jpg)